Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression
M. Bagheri, G. A. Mohamed, M. A. Mohamed Saleem, N. B. Ognjenovic, H. Lu, F. W. Kolling, O. M. Wilkins, S. Das, I. S. LaCroix, S. H. Nagaraj, K. E. Muller, S. A. Gerber, T. W. Miller, D. R. Pattabiraman
The paper shows that eribulin induces MET in mesenchymal-like TNBC cells, reducing metastatic potential and increasing sensitivity to other chemotherapeutics.
bioRxiv · Apr 19, 2023 · PreprintCancer Biology